Ambo Agritec reschedules FY26 board meeting to June 4
Ambo Agritec Limited has moved its board meeting to June 4, 2026, to approve the audited financial results for the year ended March 31, 2026, citing the CFO's ill health and missing documents. Consequently, the trading window for the company's securities will remain closed until June 6, 2026.

*this image is generated using AI for illustrative purposes only.
Ambo Agritec Limited has rescheduled its board meeting to June 4, 2026, to consider and approve the standalone and consolidated audited financial results for the financial year ended March 31, 2026. The meeting was originally set for May 30, 2026, but was postponed due to the sudden ill health of the Chief Financial Officer (CFO) and the non-availability of certain required financial documents and clarifications. This rescheduling is conducted in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has confirmed that the trading window for dealing in its securities will continue to remain closed until June 6, 2026. This extension ensures the window stays shut until the expiry of 48 hours after the unpublished price-sensitive information is submitted to the stock exchanges, adhering to the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons. The initial closure was communicated via a letter dated March 23, 2026.
Key Meeting Details
| Event | Date |
|---|---|
| Board Meeting | June 4, 2026 |
| Financial Year End | March 31, 2026 |
| Trading Window Reopens | June 6, 2026 |
Historical Stock Returns for AMBO Agritec
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.83% | -14.06% | -21.43% | -70.32% | -81.53% | -67.34% |
How might the delay in releasing the audited results impact investor sentiment and stock volatility leading up to June 4?
What are the potential implications for Ambo Agritec's financial performance given the CFO's sudden ill health and missing documents?
Will the company provide any guidance or outlook for the upcoming fiscal year during the rescheduled board meeting?




























